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Drosophila is proving to be a valu-able model for studying aggressive 
tumors induced by the combined activa-
tion of EGFR and JAK-STAT signaling. 
Here we summarize some of the most 
recent data showing that tissue damage 
and the modulation of common pathway 
regulators are at the heart tumor progres-
sion and metastasis.
Cancer is a complex disease in which a 
variety of signals contribute to tumor gen-
eration and progression. This complexity 
is increased if we consider how the inter-
action of the tumor with its cellular envi-
ronment contributes to the regression or 
expansion and aggressiveness of the lesion.
Remarkable advances have been made 
to treat different types of cancer. However, 
treatments based on the true elimination 
of tumor cells at early stages of cancer pro-
gression would be crucial to improve the 
yield of successful therapies. Early factors 
that trigger tumor development can be 
studied in Drosophila, a genetically trac-
table model organism.
Given the large evolutionary distances 
separating Drosophila and humans, flies 
may seem a bad choice as model system 
for cancer research. However, experi-
ments done in the last few years proved 
that tumors can be readily induced in 
Drosophila by expressing or mutating the 
same genes involved in human tumors.
More than 68% of the genes involved 
in human cancer are conserved in 
Drosophila,1 among others the EGFR 
and JAK-STAT pathways. The potent 
Drosophila tool-kit developed to study 
the involvement of these pathways in 
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normal development is now being used 
to find out how these genes control cell 
proliferation and how in some conditions 
their abnormal regulation induces aggres-
sive tumors. The unparalleled capacity 
for genetic manipulation in Drosophila 
permits activating or repressing any gene 
combination in labeled cells at particular 
regions. This allows studying how these 
genes induce over proliferation, metasta-
sis and how the tumorous tissue displaces 
the normal cells. These techniques also 
allow the systematic activation of other 
genes in the tumor in order to iden-
tify new molecules that suppress tumor 
growth and therefore could become drug 
targets to treat tumors in humans. In this 
commentary we want to discuss recent 
developments describing how simulta-
neous misregulation of the EGFR and 
the JAK-STAT pathways in Drosophila 
epithelial cells induce carcinomas, how 
this carcinomas interact with the cellu-
lar microenvironment and how competi-
tion between normal and tumorous cells 
leads to the regression or expansion of the 
tumor.
It had been observed that activating the 
EGFR pathway in flies, either by ectopi-
cally expressing the receptor or by activat-
ing its downstream target Ras (with the 
constitutively activated RasV12 mutation), 
can cause benign epithelial tumors. In 
these tumors the epithelial tissues over 
proliferate without the cells losing their 
epithelial character, with clear apical local-
ization of E-cadherin and maintenance of 
the cell polarity2-4 (Fig. 1A and B). Later 
work showed that mutation of second-
ary genes in cells with overactive EGFR 
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as mutant flies develop epithelial tissue 
overgrowth that eventually kills the ani-
mal (explaining the telling names of these 
mutations). Surprisingly, instead of form-
ing a tumor, small groups of cells carry-
ing mutations of these epithelial polarity 
genes are eliminated from the tissue by 
competition with the surrounding normal 
cells.
A very different situation arises when 
mutations on scrib, dlg or lgl occur in Ras 
activated cells. In this case the double 
mutant cells survive the competition and 
become metastatic2,4 proving that, as in 
humans, tumor aggressiveness results 
from more than one lesion. To investi-
gate why this gene combination causes 
such invasiveness, the fly tumors were 
studied by microarray analysis and it was 
found that the three upd ligands of the 
Drosophila JAK-STAT pathway where 
highly upregulated.7 Studying the func-
tional requirement of JAK-STAT signal-
ing in these tumors was facilitated by 
the simplicity of the Drosophila pathway 
that consists of a single receptor (dome), a 
single JAK kinase and a single STAT tran-
scription factor (Stat92E).8,9 This allowed 
to find that the tumors caused by activated 
RasV12 and scrib− mutants were suppressed 
by expression of a dominant negative 
JAK-STAT receptor or by mutation of the 
Stat92E gene7 suggesting that the EGFR 
tumor becomes much more aggressive by 
the simultaneous activation of the JAK-
STAT pathway. This point was confirmed 
by the observation that expressing the upd 
ligands in Ras activated cells results in 
large metastatic tumors. It was also found 
that the activation of the upd ligands in 
scrib− mutant cells with affected polarity 
was mediated by the JNK pathway acti-
vation. Indeed, mutating the Jun kinase 
gene basket in RasV12 scrib− mutant cells 
suppressed the metastasis. Interestingly, 
the same mutation is unable to suppress 
tumors caused by ectopic upd ligand in 
RasV12 cells, indicating that the loss of cell 
polarity activates the JNK pathway that in 
turn activates JAK-STAT (Fig. 1C). Thus, 
the co-activation of JAK-STAT and the 
EGFR pathway is ultimately responsible 
for the aggressive carcinoma as blocking 
JAK-STAT activation at any level can 
ameliorate the tumor progression in RasV12 
cells.
The Scribble (scrib), lethal (2) giant 
larvae (lgl) and discs-large (dlg) genes 
encode proteins that form a complex on 
the basolateral membrane that is necessary 
to maintain normal epithelial cell polar-
ity. These genes are tumor supressors5,6 
pathway could cause over-proliferation 
and induce aggressive carcinomas that 
metastasize.2,4 Especially interesting was 
the interaction found between cell polar-
ity mutations and EGFR pathway acti-
vated cells.
Figure 1. The combined action of egFr and JAK-STAT signaling results in tumor progression.  
(A) epithelial growth in tissues with normal apico-basal cell polarity is controlled by the balanced 
activity of egFr, JAK-STAT and other signaling pathways. negative regulators such as Socs36E 
control pathway activity by modulating signaling output. (B) When egFr is over activated (shown 
in bold), the epithelium proliferates excessively without necessarily causing metastasis. (C) over 
proliferation and metastasis are promoted by the combined misregulation of egFr and high 
JAK-STAT expression when the signaling balance is broken by the downregulation of Socs36E by 
bantam mirnA expression or by JnK mediated JAK-STAT activation.
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occur and instead the scrib− clone over-
grows. Thus, these findings show that Stat 
protects the tissue from invasiveness.
Are these observations relevant for 
human metastasis? The conservation of 
the pathways and regulatory elements 
suggest they are, and some observations 
indicate there is a deeper conservation in 
the metastatic processes that goes further 
than those unveiled by sequence conser-
vation. Although Drosophila Socs36E has 
got in SOCS5 a human ortholog, there is 
no homology between bantam miRNA 
and any human miRNA. SOCS5 behaves 
as a tumor suppressor in an EGFR/RAS 
dependent cell transformation assay.10 
Recent work shows that a similar genetic 
interaction to that of bantam and Socs36E, 
occurs in vertebrate tumor endothelial 
co-cultures with SOCS5 and the miR-9 
miRNA.20 miR-9 is secreted from mela-
noma cells but not from normal skin 
melanocites and is taken up by endothe-
lial cells where SOCS5 is downregulated 
and as a result STAT1 becomes activated. 
This activation induces the migration 
of endothelial cells toward the tumor. 
Downregulation of JAK activation reverts 
the endothelial growth. This mechanism 
of regulation reveals a functional similar-
ity between Drosophila and humans even 
though there are clear sequence differ-
ences between the miRNAs involved and 
even between the target tissues.
These studies and the functional simi-
larities they uncover should make us aware 
that, as humans, we should keep a selfish 
interest on the developments in fly tumor 
research.
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that the EGFR JAK-STAT cocktail is 
responsible for the aggressive tumorous 
overgrowth.
Why do EGFR JAK-STAT metastatic 
tumors displace the normal tissues? A 
possible explanation comes from the pro-
cess of cell competition where it has been 
shown that cells that proliferate faster dis-
place normal neighboring cells that pro-
liferate less.17 Cell competition has been 
observed to occur among cells with dif-
ferent levels of ribosomal proteins, Myc 
or Yorkie, but a recent paper provides data 
suggesting that cells with higher activa-
tion of JAK-STAT pathway are more com-
petitive than cells with lower levels.18 The 
authors showed this in two ways: First, 
they induced simultaneously a clone of 
homozygous Stat92E mutant cells and a 
neighboring clone of wild-type cells and 
observed that the Stat92E mutant clone 
gave rise to less daughter cells than the 
wild type. This was not due to an intrin-
sic defect in the Stat92E mutant cells, as 
using established systems that increase cell 
competitiveness during development (for 
example when they produce more ribo-
somal proteins than the wild-type cells) 
allowed the Stat92E clone to proliferate 
normally. Second, they showed that acti-
vation of the JAK kinase has the comple-
mentary effect, making cells proliferate 
more efficiently and out-compete their 
wild-type neighbors. Mechanistically, cell 
competition is due to the JAK activated 
cells inducing apoptosis on the neigh-
boring wild-type cells, allowing the first 
to occupy a larger fraction of the tissue. 
Despite the over-proliferation the final tis-
sue is not overtly aberrant in shape, indi-
cating that the competitive advantage is 
checked by the normal developmental and 
homeostatic controls. Although it is not 
yet clear how the activation of the JAK-
STAT pathway transforms cells into super 
competitors, it is an interesting avenue of 
research that may help understanding how 
the EGFR JAK-STAT cocktail induces 
cells to become highly invasive.
Another recent paper demonstrates 
that cells require Stat for competitive fit-
ness to eliminate neighboring scrib− cells.19 
scrib− clones are eliminated by cell compe-
tition when surrounded by normal cells. 
However, when scrib− cells are abutting 
Stat92E− cells, the elimination does not 
Although in the above-described exper-
iments the loss of polarity and the activa-
tion of the EGFR pathway both happen 
in the tumor cells, metastatic tumors also 
appear if the polarity defect is induced in 
the neighbor cells to those where Ras is 
active.7 This implies a non-clonal origin of 
the tumor with cell interactions inducing 
the metastatic behavior. In this last case 
the scrib− cells were instrumental for start-
ing the aggressive tumor by inducing the 
JNK pathway. JNK activation from scrib− 
mutant cells can spread to the neighboring 
RasV12 cells that will activate JAK-STAT 
signaling. Although the scrib− mutant cells 
eventually disappear due to cell competi-
tion, they activated the invasive cocktail of 
factors that allow the activated RasV12 cells 
to become metastatic.7
In their recent publication Herranz 
and collaborators explore how this EGFR 
JAK-STAT oncogenic activation cock-
tail may act.10 In this work the authors 
were investigating Drosophila genes that 
would increase the proliferation poten-
tial of EGFR overexpressing cells. They 
found that co-expression of EGFR with 
the bantam microRNA (miRNA), which 
has been shown to be involved in growth 
control,11,12 results in massive epithelial 
overgrowth accompanied by a loss of epi-
thelial polarity that is not observed when 
the genes are expressed independently. 
The authors show that expression of 
EGFR results in activation of Socs36E in 
the epithelium, and that bantam miRNA 
exacerbates the EGFR overexpression 
consequences through the downregu-
lation of Socs36E expression. A similar 
effect to bantam expression is achieved if 
the EGFR is coexpressed with a Socs36E 
RNAi. Thus the activation of Socs36E 
establishes a brake to EGFR over prolifera-
tion and metastasis that is lifted by ban-
tam expression (Fig. 1C). In Drosophila, 
Socs36E is a direct transcriptional target of 
JAK-STAT and Socs36E has been shown 
to downregulate EGFR and JAK-STAT 
signaling.13-16 Herranz and collaborators 
show that bantam expression or Socs36E 
downregulation lead to a strong activation 
of JAK-STAT in EGFR overexpressing 
cells. Downregulation of the JAK-STAT 
receptor dome or the Stat92E transcrip-
tion factor in these metastatic cells results 
in tumor size normalization, indicating 
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